Abstract

Acute liver failure is a fatal syndrome attributed to massive hepatocyte apoptosis that is resistant to conventional medical therapies. Consequently, liver transplantation is required in many cases. An experimental liver failure model induced by galactosamine (Gal) and lipopolysaccharide (LPS) mimics clinical acute liver failure. In this model, LPS stimulates macrophages to release TNFα, which induces apoptosis in Gal-sensitized hepatocytes, causing acute liver failure. Hydrogen sulphide (H2S), which is an endogenously produced gaseous signaling molecule, has anti-apoptotic as well as anti-inflammatory properties. Previously, we reported that H2S attenuates liver dysfunction arising from LPS-induced systemic inflammation [1]. It has also been reported that H2S reduces hepatic ischemia/reperfusion injury by inhibition of apoptosis in the liver [2]. However, it is still unknown whether H2S exerts hepatoprotective effects against acute liver failure, in which both inflammatory responses and apoptosis have critical roles. Here, we examined the impact of H2S on acute liver failure in mice induced by Gal and LPS.

Highlights

  • Acute liver failure is a fatal syndrome attributed to massive hepatocyte apoptosis that is resistant to conventional medical therapies

  • H2S inhalation after Gal/LPS challenge further augmented phosphorylation of STAT3 compared to air alone

  • The protective effects of H2S inhalation after Gal/LPS challenge were associated with upregulation of gene expression of antiinflammatory IL-10, which stimulates STAT3 phosphorylation, in the liver

Read more

Summary

Introduction

Acute liver failure is a fatal syndrome attributed to massive hepatocyte apoptosis that is resistant to conventional medical therapies. An experimental liver failure model induced by galactosamine (Gal) and lipopolysaccharide (LPS) mimics clinical acute liver failure. In this model, LPS stimulates macrophages to release TNFa, which induces apoptosis in Gal-sensitized hepatocytes, causing acute liver failure. It has been reported that H2S reduces hepatic ischemia/reperfusion injury by inhibition of apoptosis in the liver [2]. It is still unknown whether H2S exerts hepatoprotective effects against acute liver failure, in which both inflammatory responses and apoptosis have critical roles. We examined the impact of H2S on acute liver failure in mice induced by Gal and LPS

Results
Conclusions
Tokuda K
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.